CSIMarket Company Name, Ticker, Suppliers, else..
 
Aquestive Therapeutics Inc   (NASDAQ: AQST)
 

Aquestive Therapeutics Inc's Suppliers Performance

AQST's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
AQST Costs vs Sales of Suppliers Growth Aquestive Therapeutics Inc's cost of sales deteriorated by -11.93 % year on year, sequentially cost of sales grew by 15.8 % in Q2.

• More on AQST Suppliers



Aquestive Therapeutics Inc's cost of sales deteriorated by -11.93 % year on year, sequentially cost of sales grew by 15.8 % in Q2.

• More on AQST Suppliers




Aquestive Therapeutics Inc's Comment on Supply Chain


The company sources raw materials, including active pharmaceutical ingredients, from qualified vendors both domestically and internationally, employing a multi-supplier strategy for critical materials when feasible. Product packaging foil is obtained from a single manufacturer operating multiple facilities. Clinical trials are conducted and administered by third-party contract research organizations under the company's supervision. Notable suppliers mentioned include Teva, which markets EpiPen, and Viatris, Inc., which markets generic versions of EpiPen.

Aquestive Therapeutics Inc's Comment on Supply Chain


The company sources raw materials, including active pharmaceutical ingredients, from qualified vendors both domestically and internationally, employing a multi-supplier strategy for critical materials when feasible. Product packaging foil is obtained from a single manufacturer operating multiple facilities. Clinical trials are conducted and administered by third-party contract research organizations under the company's supervision. Notable suppliers mentioned include Teva, which markets EpiPen, and Viatris, Inc., which markets generic versions of EpiPen.







AQST's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Aquestive Therapeutics Inc 594.97 54.09 -78.23 147
SUBTOTAL 0.00 0.00 0.00 -


Sources: Aquestive Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Aquestive Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.